Malignant Lip and Oral Cavity Neoplasm — Trials

Malignant Lip and Oral Cavity Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

554 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 149
Recruiting: 77
Ph III recruiting: 11
Growth YoY: +9.8%
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: 26.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07827872	Neoadjuvant Sintilimab Plus Chemotherapy for cT2N0M0 Oral Squamous Cell Carcinoma	not yet recruiting	Phase 3	300	caohaotianOTHER	1	Sep 18, 2026	clinicaltrials
NCT07667296	APG-157 in Locally Advanced Head and Neck Squamous Cell Carcinoma	not yet recruiting	Phase 3	826	Aveta Biomics, Inc.INDUSTRY	0	Jul 1, 2026	clinicaltrials
NCT07402538